These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 29376433)

  • 1. Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease.
    Sinhmar GK; Shah NN; Chokshi NV; Khatri HN; Patel MM
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1078-1089. PubMed ID: 29376433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease.
    Sinhmar GK; Shah NN; Rawal SU; Chokshi NV; Khatri HN; Patel BM; Patel MM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):565-578. PubMed ID: 29661024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.
    Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V
    Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
    Wang W; Chen L; Huang X; Shao A
    AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication, optimization, and
    Mathur P; Sharma S; Rawal S; Patel B; Patel MM
    J Liposome Res; 2020 Jun; 30(2):182-196. PubMed ID: 31060404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
    Beg S; Saini S; Bandopadhyay S; Katare OP; Singh B
    Drug Dev Ind Pharm; 2018 Mar; 44(3):407-420. PubMed ID: 29048242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Oral Lipid Based Nano-formulation of Dapagliflozin: Optimization, in vitro Characterization and ex vivo Intestinal Permeation Study.
    Zafar A
    J Oleo Sci; 2020; 69(11):1389-1401. PubMed ID: 33132278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box-Behnken design.
    Kaur P; Garg T; Rath G; Murthy RS; Goyal AK
    Drug Deliv; 2016 Jul; 23(6):1912-25. PubMed ID: 25544602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery.
    Lakhani P; Patil A; Wu KW; Sweeney C; Tripathi S; Avula B; Taskar P; Khan S; Majumdar S
    Int J Pharm; 2019 Dec; 572():118771. PubMed ID: 31669555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles.
    Das S; Ng WK; Tan RB
    Nanotechnology; 2014 Mar; 25(10):105101. PubMed ID: 24531790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
    Noor NM; Sheikh K; Somavarapu S; Taylor KMG
    Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, characterization and skin permeating potential of Fluocinolone acetonide loaded nanostructured lipid carriers for topical treatment of psoriasis.
    Pradhan M; Singh D; Murthy SN; Singh MR
    Steroids; 2015 Sep; 101():56-63. PubMed ID: 26049018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
    Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
    Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of formulation design on lipid-based nanostructured carrier system for drug delivery to brain.
    Salunkhe SS; Bhatia NM; Bhatia MS
    Drug Deliv; 2016 May; 23(4):1306-16. PubMed ID: 25080227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
    Abdelbary G; Haider M
    Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metronidazole-loaded nanostructured lipid carriers to improve skin deposition and retention in the treatment of rosacea.
    Shinde UA; Parmar SJ; Easwaran S
    Drug Dev Ind Pharm; 2019 Jul; 45(7):1039-1051. PubMed ID: 30727789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and optimization of transferrin-conjugated nanostructured lipid carriers for brain delivery of paclitaxel using Box-Behnken design.
    Emami J; Rezazadeh M; Sadeghi H; Khadivar K
    Pharm Dev Technol; 2017 May; 22(3):370-382. PubMed ID: 27689412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration.
    Song A; Zhang X; Li Y; Mao X; Han F
    Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.